Thomas Haughey - Net Worth and Insider Trading

Thomas Haughey Net Worth

The estimated net worth of Thomas Haughey is at least $2 Million dollars as of 2024-12-12. Thomas Haughey is the Director of ANI Pharmaceuticals Inc and owns about 30,202 shares of ANI Pharmaceuticals Inc (ANIP) stock worth over $2 Million. Details can be seen in Thomas Haughey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Haughey has not made any transactions after 2021-12-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Thomas Haughey

To

Thomas Haughey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Haughey owns 1 companies in total, including ANI Pharmaceuticals Inc (ANIP) .

Click here to see the complete history of Thomas Haughey’s form 4 insider trades.

Insider Ownership Summary of Thomas Haughey

Ticker Comapny Transaction Date Type of Owner
ANIP ANI Pharmaceuticals Inc 2021-12-06 director

Thomas Haughey Latest Holdings Summary

Thomas Haughey currently owns a total of 1 stock. Thomas Haughey owns 30,202 shares of ANI Pharmaceuticals Inc (ANIP) as of December 6, 2021, with a value of $2 Million.

Latest Holdings of Thomas Haughey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANIP ANI Pharmaceuticals Inc 2021-12-06 30,202 59.17 1,787,052

Holding Weightings of Thomas Haughey


Thomas Haughey Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas Haughey has made a total of 2 transactions in ANI Pharmaceuticals Inc (ANIP) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in ANI Pharmaceuticals Inc is the acquisition of 2,500 shares on December 6, 2021, which cost Thomas Haughey around $98,450.

Insider Trading History of Thomas Haughey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas Haughey Trading Performance

GuruFocus tracks the stock performance after each of Thomas Haughey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Haughey is -15.42%. GuruFocus also compares Thomas Haughey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Haughey within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Thomas Haughey's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Thomas Haughey

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.61 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.04 LIMIT LIMIT LIMIT LIMIT LIMIT

Thomas Haughey Ownership Network

Ownership Network List of Thomas Haughey

No Data

Ownership Network Relation of Thomas Haughey

Insider Network Chart

Thomas Haughey Owned Company Details

What does ANI Pharmaceuticals Inc do?

Who are the key executives at ANI Pharmaceuticals Inc?

Thomas Haughey is the director of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include director & PRESIDENT & CEO Nikhil Lalwani , HEAD OF RARE DISEASE Christopher Mutz , and SR. VP & GENERAL COUNSEL & SEC. Meredith Cook .

ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary

Over the past 18 months, Thomas Haughey made no insider transaction in ANI Pharmaceuticals Inc (ANIP). Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 776,190 shares made by Muthusamy Shanmugam , a net sale of 3,250 shares made by Meredith Cook , and a net sale of 200,000 shares made by Chad Gassert .

In summary, during the past 3 months, insiders sold 40,731 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 40,731 shares. During the past 18 months, 1,451,493 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,451,493 shares.

ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ANI Pharmaceuticals Inc Insider Transactions

No Available Data

Thomas Haughey Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Haughey. You might contact Thomas Haughey via mailing address: One Ram Ridge Road, C/o Par Pharmaceutical, Chestnut Ridge Ny 10977.